|
|
Clinical correlation factors of serum osteocalcin levels in middle-aged and elderly men undergoing health checkups |
LV Jungang1, ZHAI Li1, WANG Na1, ZHANG Lin1, CAO Tiantian1, LIANG Hongwei2 |
1. The Third Department of Internal Medicine, 2. The Second Department of Surgery, Beijing Municipal Corps Hospital of Chinese People's Armed Police Force, Beijing 100027, China |
|
|
Abstract Objective To investigate the relationship between serum osteocalcin (OC) levels and biochemical markers of bone turnover, sex hormones, and blood test indicators in middle-aged and elderly men undergoing health checkups, and analyze the clinical correlation factors of serum OC. Methods A retrospective analysis was conducted on 793 cases of middle-aged and elderly men who underwent health checkups in hospital from January 2023 to December 2023, and the subjects was divided into a low OC group (OC<14 ng/ml) and a normal OC group (14 ng/ml≤ OC ≤ 46 ng/ml) based on serum OC measurement values. General clinical data, blood test indicators, sex hormones, and biochemical markers of bone turnover were collected, and the relationship between serum OC levels and various indicators was analyzed. Results There were 539 (67.97%) in the low OC group and 254 (32.03%) in the normal OC group. The average age, white blood cell count, fasting blood glucose, glycosylated hemoglobin A1c(HbA1c), and estradiol of the low OC group were higher than those of the normal OC group. The average total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, serum alkaline phosphatase (BALP), blood phosphorus, blood sodium, blood chloride, parathyroid hormone (PTH), type I procollagen N-terminal propeptide (PINP), and β-collagen specific sequence (β-CTX) were all lower than those of the normal OC group, with statistically significant differences (P<0.05). Serum OC was positively correlated with PTH (r=0.315,P<0.001),PINP (r=0.755,P<0.001),β-CTX (r= 0.761,P<0.001), BALP (r=0.340,P<0.001), and blood phosphorus (r=0.118,P=0.001). The results of multiple linear regression analysis showed that age (β=-0.16, P=0.001), white blood cell count (β=-0.151, P<0.001), HbA1c (β-.148, P=0.001), homocysteine, (β=0.083, P= 0.007), blood phosphorus (β=0.215, P<0.001), serum testosterone (β=-0.110, P=0.006), PTH (β=0.265, P<0.001), and BALP (β=0.319, P<0.001) could predict the change of serum OC. Conclusions Age, inflammation, sex hormones, and some biochemical markers of bone turnover are correlated with serum OC in middle-aged and elderly men, and controlling inflammation, maintaining a good blood glucose level, estrogen/androgen balance, and endocrine homeostasis are beneficial for maintaining healthy bone metabolism in middle-aged and elderly men.
|
Received: 22 October 2024
|
|
|
|
|
[1] |
Aibar A A,Voltes M A,Castellote C Y,et al.Current status of the diagnosis and management of osteoporosis[J].Int J Mol Sci,2022,23(16):9465.
|
[2] |
Wang L,Yu W,Yin X,et al.Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study[J].JAMA Netw Open,2021,4(8):e2121106.
|
[3] |
Vilaca T,Eastell R, Schini M. Osteoporosis in men[J]. Lancet Diabetes Endocrinol, 2022, 10(4):273-283.
|
[4] |
Schini M,Vilaca T,Gossiel F,et al.Bone turnover markers: basic biology to clinical applications[J].Endocr Rev,2023,44(3):417-473.
|
[5] |
Ma J,Han L,Zhou X,et al.Clinical significance of Vitamin-D and other bone turnover markers on bone mineral density in patients with gestational diabetes mellitus[J].Pak J Med Sci,2022,38(1):23-27.
|
[6] |
Brown J P,Don-Wauchope A,Douville P,et al.Current use of bone turnover markers in the management of osteoporosis[J].Clin Biochem,2022,109-110:1-10.
|
[7] |
Liang F,Sun L,Wang Y.The relationship between GNRI changes and bone metabolism parameters and the occurrence of osteoporosis in elderly male patients with T2D[J].Altern Ther Health Med,2023,29(1):85-89.
|
[8] |
邢时妹,曹永红,戴 武.绝经后女性2型糖尿病病人骨钙素水平与糖尿病肾脏病的相关性研究[J].安徽医药,2022,26 (9):1818-1821.
|
[9] |
Bouvard B,Annweiler C,Legrand E.Osteoporosis in older adults[J].Joint Bone Spine,2021,88(3):105135.
|
[10] |
Qian Z,Liu C,Li H,et al.Osteocalcin alleviates lipopolysaccharide-induced acute inflammation via activation of GPR37 in macrophages[J].Biomedicines,2022,10(5):1006.
|
[11] |
杨文婷.高同型半胱氨酸血症与老年患者骨质疏松症发生的相关性调查[J].中华养生保健,2024,42(17):188-191.
|
[12] |
周亚捷,姚反修,杨 默,等.老年高血压NSF-1、25(OH)D及Hcy水平与骨质疏松症的关系[J].分子诊断与治疗杂志,2022,14(4):673-676.
|
[13] |
温娟娟,孟 涛,卜 佳,等.男性2型糖尿病患者骨密度的影响因素[J].中国医药导报,2022,19(10):107-110.
|
[14] |
Viswanath A,Vidyasagar S,Amrutha S C.Osteocalcin and metabolic syndrome[J].Clin Med Insights Endocrinol Diabetes,2023,16:1179.
|
[15] |
Guo X,Yang Y Y,Zhou R,et al.Causal effect of blood osteocalcin on the risk of Alzheimer's disease and the mediating role of energy metabolism[J].Transl Psychiatry,2024,14(1):205.
|
[16] |
张延祺,王 玙,刘建清,等.福州地区老年人群脂代谢、糖代谢状况调查[J].华南预防医学,2023,49(2): 146-149,155.
|
[17] |
Jia L,Cheng M.Correlation analysis between risk factors, BMD and serum osteocalcin, CatheK, PINP, β-crosslaps, TRAP, lipid metabolism and BMI in 128 patients with postmenopausal osteoporotic fractures[J].Eur Rev Med Pharmacol Sci,2022,26(21):7955-7959.
|
[18] |
Shin S,Nam H Y.Effect of obesity and osteocalcin on brain glucose metabolism in healthy participants[J]. Brain Sci,2023,13(6):889.
|
[19] |
李 霞.桥本氏病合并亚临床甲状腺功能减退患者血清骨钙素及糖脂状况研究[D].昆明:昆明医科大学, 2023.
|
[20] |
Chin K Y,Ima N S,Mohamed I N,et al.Serum osteocalcin is significantly related to indices of obesity and lipid profile in malaysian men[J].Int J Med Sci,2014,11(2):151-157.
|
[21] |
田骆冰,房 辉,徐 刚,等.中年男性2型糖尿病伴血脂异常患者骨钙素与股动脉内膜中层厚度及下肢动脉斑块的关系[J].中华糖尿病杂志,2020,6:398-403.
|
[22] |
王 鸿, 申 义, 杜扬帆, 等.2型糖尿病患者血清维生素水平及其影响因素[J].武警医学,2024, 35(1): 34-37.
|
[23] |
Saleem U,Mosley T H,Kullo I J.Serum osteocalcin is associated with measures of insulin resistance, adipokine levels,and the presence of metabolic syndrome[J].ArteriosclerThromb Vasc Biol,2010,30(7):1474-1478.
|
[24] |
David K,Narinx N,Antonio L,et al.Bone health in ageing men[J].Rev Endocr Metab Disord,2022, 23(6):1173-1208.
|
[25] |
Thirumalai A,Yuen F,Amory J K,et al.Dimethandrolone undecanoate, a novel, nonaromatizable androgen, increases P1NP in healthy men over 28 days[J].J Clin Endocrinol Metab,2021,106(1):e171-e181.
|
[26] |
Hatsukari A,Torii S.Changes of bone turnover markers and testosterone in Japanese male endurance runners: a pilot study[J].J Bone Miner Metab,2023,41(6):838-843.
|
[27] |
Karsenty G.Osteocalcin: a multifaceted bone-derived hormone[J].Annu Rev Nutr,2023,43: 55-71.
|
[28] |
Ying K E,Feng W,Ying W Z,et al.Dietary salt initiates redox signaling between endothelium and vascular smooth muscle through NADPH oxidase 4[J].Redox Biol,2022, 52:102296.
|
[29] |
Sun L,Wang Z,Zheng M,et al.Mineral and bone disorder after kidney transplantation: a single-center cohort study[J].Ren Fail,2023,45(1): 2210231.
|
|
|
|